During this bull cycle, the crypto market has been surfing off Bitcoin’s crest and enjoying the bullish momentum. However, investors hope for a seismic explosion to impulse Altcoins to new highs.
Related Reading
As the crypto industry awaits, online reports revealed that, since FTX’s fall, only eight altcoins have hit a new all-time high (ATH) against Bitcoin. A crypto analyst shared his thoughts on the matter.
Altcoins Underperforming Against Bitcoin This Cycle
On Friday, Crypto analyst Miles Deutscher shared an interesting fact about the crypto market. Since November 2022, just eight altcoins have broken their previous ATH against the flagship cryptocurrency.
To achieve this feat, tokens include Render (RNDR), Tellor (TRB), Injective (INJ), Astar (ASTR), SSV Network (SSV), SingularityNET (AGIX), True Wallet Token (TWT), and Binance Coin (BNB).
It’s worth noting that RNDR was the latest one to accomplish this on March 11 and that the list only contains altcoins launched before FTX’s collapse.
Deutscher explained that despite his initial shock, the news made sense to him and highlighted some takeaways based on the singularities of this run.
First, the analyst considers that asset selection dynamics changed from previous cycles. Investors have been “punished” for being overexposed to certain sectors like L2 and gaming and “rewarded” for participating in others like Memecoins and AI.
In contrast, in the last cycle, “you could basically bet on anything and beat $BTC.” According to the analyst, the market will likely continue experiencing specific sector outperformance despite the retail liquidity injection.
He also explained that “crypto is an attention economy,” and money will flow where attention is. As a result, even the projects with the best technology won’t perform if there isn’t an exciting reason to buy.
Deutscher’s second takeaway highlights the market’s current ATH dilution. As he points out, thousands of new products are being launched daily, and “low float/high FDV VC coins are launching in the billions.” These launches are seemingly outpacing the new liquidity, resulting in Altcoins struggling with performance.
More Room To Catch Up
The analyst’s third point explains that the bull run has been led by Bitcoin and spot BTC exchange-traded funds (ETH). Based on this, he considers it unsurprising that altcoins have “hardly pumped” so far.
Various crypto analysts and experts share this opinion. Alex Krüger previously stated that the cycle has been “almost entirely” driven by the Bitcoin ETFs’ momentum.
Deutscher sees Altcoins’ underperformance as a bullish signal since Bitcoin’s dominance has been instrumental in previous cycles. To him, this performance allows “more room to play catch up” and could drive altcoins to unseen highs.
Related Reading
The analyst believes the market needs another catalyst for a true Altcoins season. Despite this, he highlights that many investors have had a record Q1 “even in mildly bullish conditions for most alts.”
Ultimately, Deutscher considers there is still room to make big profits this cycle “even without the face-melting altseason we all crave.”
Featured Image from Unsplash.com, Chart from TradingView.com
During this bull cycle, the crypto market has been surfing off Bitcoin’s crest and enjoying the bullish momentum. However, investors hope for a seismic explosion to impulse Altcoins to new highs.
Related Reading
As the crypto industry awaits, online reports revealed that, since FTX’s fall, only eight altcoins have hit a new all-time high (ATH) against Bitcoin. A crypto analyst shared his thoughts on the matter.
Altcoins Underperforming Against Bitcoin This Cycle
On Friday, Crypto analyst Miles Deutscher shared an interesting fact about the crypto market. Since November 2022, just eight altcoins have broken their previous ATH against the flagship cryptocurrency.
To achieve this feat, tokens include Render (RNDR), Tellor (TRB), Injective (INJ), Astar (ASTR), SSV Network (SSV), SingularityNET (AGIX), True Wallet Token (TWT), and Binance Coin (BNB).
It’s worth noting that RNDR was the latest one to accomplish this on March 11 and that the list only contains altcoins launched before FTX’s collapse.
Deutscher explained that despite his initial shock, the news made sense to him and highlighted some takeaways based on the singularities of this run.
First, the analyst considers that asset selection dynamics changed from previous cycles. Investors have been “punished” for being overexposed to certain sectors like L2 and gaming and “rewarded” for participating in others like Memecoins and AI.
In contrast, in the last cycle, “you could basically bet on anything and beat $BTC.” According to the analyst, the market will likely continue experiencing specific sector outperformance despite the retail liquidity injection.
He also explained that “crypto is an attention economy,” and money will flow where attention is. As a result, even the projects with the best technology won’t perform if there isn’t an exciting reason to buy.
Deutscher’s second takeaway highlights the market’s current ATH dilution. As he points out, thousands of new products are being launched daily, and “low float/high FDV VC coins are launching in the billions.” These launches are seemingly outpacing the new liquidity, resulting in Altcoins struggling with performance.
More Room To Catch Up
The analyst’s third point explains that the bull run has been led by Bitcoin and spot BTC exchange-traded funds (ETH). Based on this, he considers it unsurprising that altcoins have “hardly pumped” so far.
Various crypto analysts and experts share this opinion. Alex Krüger previously stated that the cycle has been “almost entirely” driven by the Bitcoin ETFs’ momentum.
Deutscher sees Altcoins’ underperformance as a bullish signal since Bitcoin’s dominance has been instrumental in previous cycles. To him, this performance allows “more room to play catch up” and could drive altcoins to unseen highs.
Related Reading
The analyst believes the market needs another catalyst for a true Altcoins season. Despite this, he highlights that many investors have had a record Q1 “even in mildly bullish conditions for most alts.”
Ultimately, Deutscher considers there is still room to make big profits this cycle “even without the face-melting altseason we all crave.”
Featured Image from Unsplash.com, Chart from TradingView.com
clomid generic cost buy generic clomiphene pill buy clomid where can i buy clomid where to get cheap clomiphene no prescription can i purchase clomiphene for sale where to get cheap clomiphene tablets
Hi, I think your site might be having browser compatibility issues. When I look at your website in Firefox, it looks fine but when opening in Internet Explorer, it has some overlapping. I just wanted to give you a quick heads up! Other then that, excellent blog!
More posts like this would prosper the blogosphere more useful.
Thanks an eye to sharing. It’s first quality.
buy azithromycin 500mg – order sumycin 500mg sale order metronidazole pill
cost semaglutide – rybelsus 14mg without prescription order periactin pills
domperidone canada – buy tetracycline 250mg online cheap purchase cyclobenzaprine online cheap
order generic inderal – order methotrexate 2.5mg online cheap methotrexate 10mg uk
buy generic amoxicillin for sale – purchase combivent online cheap buy cheap combivent
amei este site. Para saber mais detalhes acesse nosso site e descubra mais. Todas as informações contidas são informações relevantes e exclusivos. Tudo que você precisa saber está ta lá.
fantástico este conteúdo. Gostei bastante. Aproveitem e vejam este conteúdo. informações, novidades e muito mais. Não deixem de acessar para saber mais. Obrigado a todos e até mais. 🙂
buy zithromax paypal – zithromax 250mg over the counter order bystolic generic
amoxiclav for sale – https://atbioinfo.com/ buy ampicillin generic
esomeprazole 20mg generic – https://anexamate.com/ cheap nexium 20mg
buy warfarin 2mg online cheap – blood thinner losartan drug
Some truly interesting information, well written and broadly speaking user genial.
order meloxicam 7.5mg online cheap – relieve pain brand meloxicam
prednisone tablet – https://apreplson.com/ order deltasone 20mg pills
cheap ed pills – https://fastedtotake.com/ where to buy ed pills
order amoxicillin without prescription – https://combamoxi.com/ order amoxicillin for sale
generic diflucan 200mg – https://gpdifluca.com/# diflucan cheap
order cenforce 50mg for sale – https://cenforcers.com/ buy cenforce 100mg generic
cialis store in philippines – https://strongtadafl.com/# buy cialis overnight shipping
order ranitidine pill – how to buy zantac order ranitidine for sale
The thoroughness in this draft is noteworthy. https://gnolvade.com/es/comprar-viagra-en-espana/
More articles like this would make the blogosphere richer. https://buyfastonl.com/isotretinoin.html
More posts like this would create the online space more useful. https://ursxdol.com/synthroid-available-online/
More posts like this would persuade the online elbow-room more useful. https://prohnrg.com/product/orlistat-pills-di/
I’ve read a few good stuff here. Certainly worth bookmarking for revisiting. I wonder how much effort you put to create such a wonderful informative web site.
The thoroughness in this draft is noteworthy. https://aranitidine.com/fr/acheter-cenforce/
Greetings! Extremely serviceable par‘nesis within this article! It’s the little changes which choice make the largest changes. Thanks a portion for sharing! https://ondactone.com/simvastatin/
More delight pieces like this would insinuate the интернет better.
order nexium for sale
I cling on to listening to the rumor lecture about receiving free online grant applications so I have been looking around for the best site to get one. Could you advise me please, where could i find some?
Greetings! Jolly useful advice within this article! It’s the petty changes which liking turn the largest changes. Thanks a quantity quest of sharing! http://bbs.51pinzhi.cn/home.php?mod=space&uid=7059413
I am constantly thought about this, appreciate it for posting.
dapagliflozin 10 mg pills – buy forxiga paypal order forxiga 10 mg sale
orlistat sale – site xenical pill